BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28411843)

  • 1. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
    Titeux M; Izmiryan A; Hovnanian A
    J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montagna Symposium 2017-Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment.
    Tolar J; Bauer JW; Kaplan DH; Leachman SA; McGrath JA; Paller AS; Griffith-Bauer KA; Stemwedel CE; Kulesz-Martin MF
    J Invest Dermatol; 2018 Jun; 138(6):1243-1248. PubMed ID: 29550416
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating functional genomics to accelerate mechanistic personalized medicine.
    Tyner JW
    Cold Spring Harb Mol Case Stud; 2017 Mar; 3(2):a001370. PubMed ID: 28299357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning for precision dermatology: Advances, opportunities, and outlook.
    Lee EY; Maloney NJ; Cheng K; Bach DQ
    J Am Acad Dermatol; 2021 May; 84(5):1458-1459. PubMed ID: 32645400
    [No Abstract]   [Full Text] [Related]  

  • 5. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy.
    Rizzo AE; Maibach HI
    J Dermatolog Treat; 2012 Jun; 23(3):161-7. PubMed ID: 21254882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From molecules to medicines: the dawn of targeted therapies for genetic epilepsies.
    Demarest ST; Brooks-Kayal A
    Nat Rev Neurol; 2018 Dec; 14(12):735-745. PubMed ID: 30448857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dermatology comes of age.
    Has C; Sitaru C
    Methods Mol Biol; 2013; 961():1-16. PubMed ID: 23325634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic.
    Takeichi T; Nanda A; Liu L; Salam A; Campbell P; Fong K; Akiyama M; Ozoemena L; Stone KL; Al-Ajmi H; Simpson MA; McGrath JA
    Exp Dermatol; 2013 Dec; 22(12):825-31. PubMed ID: 24279917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
    Bacchelli C; Williams HJ
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.
    Lin S; Yin YA; Jiang X; Sahni N; Yi S
    Biomed Res Int; 2016; 2016():6186281. PubMed ID: 27403431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing a review of new strategies for rare genomic disease research.
    Brown TL; Meloche TM
    Genomics; 2016 Oct; 108(3-4):109-114. PubMed ID: 27387609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; LĂĽckhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic approaches to diagnose rare bone disorders.
    Falardeau F; Camurri MV; Campeau PM
    Bone; 2017 Sep; 102():5-14. PubMed ID: 27474525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing Techniques and Their Therapeutic Applications.
    Calos MP
    Clin Pharmacol Ther; 2017 Jan; 101(1):42-51. PubMed ID: 27783398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Targeted Therapies Based on Gene Modification.
    Benson TM; Leti F; DiStefano JK
    Methods Mol Biol; 2018; 1706():39-51. PubMed ID: 29423792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.